论文部分内容阅读
对泰国一个医院中罕见的卵巢恶性生殖细胞瘤(mOGCT)患者存活率和手术治疗结果进行回顾性研究。选择1990～1996年病理诊断为卵巢恶性生殖细胞瘤(mOGCT)的34例妇女。手术治疗原则:初次手术为子宫全切术—双侧输卵管卵巢切除术(TAH.BSO)的非保守术或单侧输卵管卵巢切除(USO)的保守术(用于年轻妇女保留生育功能),晚期病例配合细胞减灭术。并行结肠下网膜切除术、腹腔液细胞学检查、对可疑部位进行活检。 纯无性细胞瘤(DgS)IA期单行USO,IB～Ⅱ期行TAH.BSO后化疗3～4疗程,ⅡC～Ⅳ期晚期病例术后化疗4～6疗程。化疗无效者进一步给予
A retrospective study was performed on the survival and surgical outcome of patients with rare ovarian germ cell tumor (mOGCT) in a Thai hospital. Thirty-four women with pathologically diagnosed ovarian germ cell tumor (mOGCT) from 1990 to 1996 were selected. Surgical treatment principle: The initial surgery for hysterectomy - bilateral tubal ovariectomy (TAH.BSO) non-conservative or unilateral tubal ovariectomy (USO) conservative surgery (for young women to retain reproductive function), advanced Cases with cytoreductive surgery. Parallel colorectal omentum resection, peritoneal fluid cytology, biopsy of suspicious sites. Pure Dysplastic Stem Cell (DgS) stage IA single line USO, IB ~ stage TAH.BSO chemotherapy after 3 ~ 4 courses, Ⅱ C ~ Ⅳ advanced cases of postoperative chemotherapy 4 to 6 courses. Chemotherapy ineffective further